Pure Global

Thulium Fiber Laser Prospective Trial - Trial NCT05814133

Access comprehensive clinical trial information for NCT05814133 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre hospitalier de l'Université de Montréal (CHUM) and is currently Not yet recruiting. The study focuses on Kidney Stone. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05814133
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.govNCT05814133
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Thulium Fiber Laser Prospective Trial
Prospective Clinical Trial To Evaluate The Thulium Fiber Laser For The Ureteroscopic Treatment Of Nephrolithiasis

Study Focus

Kidney Stone

Thulium Fiber Laser

Interventional

device

Sponsor & Location

Centre hospitalier de l'Université de Montréal (CHUM)

Montreal, Canada

Timeline & Enrollment

N/A

Sep 15, 2023

Jul 15, 2024

150 participants

Primary Outcome

Mean total operative time

Summary

This is a multi-center, prospective clinical trial to assess the effect of TFL for the
 lithotripsy of kidney stones.

ICD-10 Classifications

Kidney dialysis
Small kidney, unspecified
Disorder of kidney and ureter, unspecified
Injury of kidney
Unspecified kidney failure

Data Source

ClinicalTrials.gov

NCT05814133

Device Trial